Institutional Ownership
Revolution Medicines Inc
CUSIP 76155X118*W EXP 12/17/202RVMDWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
23
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lmr Partners LLP | 3.84M | $6.87M |
| 2 | D. E. Shaw & Co., Inc. | 1.58M | $2.75M |
| 3 | Sculptor Capital LP | 958.8K | $1.70M |
| 4 | Aristeia Capital, L.L.C. | 583.6K | $1.03M |
| 5 | Caption Management, LLC | 517.7K | $926.7K |
| 6 | Adage Capital Partners Gp, L.L.C. | 500.0K | $895.0K |
| 7 | Lunate Capital Ltd | 450.0K | $805.5K |
| 8 | Perceptive Advisors LLC | 250.0K | $447.5K |
| 9 | Bleichroeder LP | 200.0K | $358.0K |
| 10 | Wolverine Asset Management LLC | 170.7K | $305.5K |